|
|
| 2006/2005 IW U.S. 500 Rank |
43/45 |
| Executive 1 |
Miles D. White, Chmn.; CEO |
| Executive 2 |
Richard W. Ashley, Exec. VP, Corp. Dev. |
| Executive 3 |
Thomas C. Freyman, Exec. VP, Finance; CFO |
| Executive 4 |
Jeffrey R. Binder, Sr. VP, Diagnostic Operations |
| Executive 5 |
William G. Dempsey, Sr. VP, Pharmaceutical Operations |
| Revenues (US$ Millions) |
22337.81 |
| Earnings Per Share (US$) |
2.16 |
| Total Equity (US$ Millions) |
14415.27 |
| Return On Equity (%) |
23.54 |
| Debt To Equity Ratio (%) |
0.32 |
| Market Capitalization (US$ Millions) |
76961.75 |
| Revenue Growth (%) |
13.51 |
